Avalo Therapeutics所有资讯

Avalo Therapeutics | 8-K：重大事件

05/23 15:07

Avalo Therapeutics | SC 13G：超过5%持股股东披露文件-Allostery Master Fund LP(7.6%),Allostery Investments LP(7.6%)等

05/13 11:44

Avalo Therapeutics | 10-Q：季度报表

05/13 06:34

Avalo Therapeutics | 8-K：Avalo公布2024年第一季度财务业绩并提供业务最新情况

05/13 06:34

Avalo Therapeutics | SC 13G：超过5%持股股东披露文件-Emerald Bioventures, LLC(5.6%),Timothy Opler(5.6%)

04/23 14:00

Avalo Therapeutics | D：发行公告

04/09 16:02

Avalo Therapeutics | SC 13G：超过5%持股股东披露文件-Deep Track Capital, LP(9.99%),Deep Track Biotechnology Master Fund, Ltd.(9.99%)等

04/05 15:04

Avalo Therapeutics | 3：首次持股声明-董事 Truex Samantha

04/03 15:13

Avalo Therapeutics | 3：首次持股声明-董事 Goldman Jonathan

04/03 15:10

Avalo Therapeutics | 3：首次持股声明-董事 KANTOFF AARON

04/03 15:04

Avalo Therapeutics | 10-K：年度报表

03/29 15:08

Avalo Therapeutics | 8-K：重大事件

03/29 15:08

Avalo Therapeutics | DEFA14A：其他

03/28 05:29

Avalo Therapeutics | 8-K：重大事件

03/28 05:14

Avalo Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(0.0%),VHCP Co-Investment Holdings III, LLC(0.0%)等

02/14 20:18

Avalo Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Great Point Partners, LLC(0.26%),Dr. Jeffrey R. Jay, M.D.(0.26%)等

02/14 16:35

Avalo Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Nantahala Capital Management, LLC(4.9%),Wilmot B. Harkey(4.9%)等

02/14 15:58

Avalo Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Point72 Asset Management, L.P.(0.3%),Point72 Capital Advisors, Inc.(0.3%)等

02/14 09:08

Avalo Therapeutics | 8-K：重大事件

01/31 15:03

Avalo Therapeutics | 8-K：重大事件

2023/12/27 23:00